

| Revenue | $100 - $500 million See Exact Annual Revenue |
|---|---|
| Employees | 500 - 1,000Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Additional NAICS Codes | 6213 Offices of Other Health Practitioners 621511 Medical Laboratories |
| Address | 333 Ludlow St N Tower Fl 8 Stamford, CT 06902 |
| Sema4 Opco | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $100 - $500 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Sema4 Opco P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| SEMA4 ELEMENTS Downloadable software for the delivery of test content and interpretations for clinical testing; downloadable software for the exchange of genetic information and genetic test results; downloadable software for women's health analysis and feedback | 09/25/2020 |
| TRAVERSA Health care services, namely, evaluating, and analyzing patient bio-specimens and genetic data and information for medical treatment and diagnostic purposes; providing bio-specimen storage and scientific analysis services for the health care industry all for medical use | 02/25/2020 |
| SEMA4 SIGNAL Oncological solutions portfolio consisting of diagnostic services in the field of medicine, medical testing for cancer risk assessment, diagnosis, treatment, and monitoring; bioinformatics analysis for medical and oncological diagnostic and personalized treatment purposes; consulting services in the field of oncological diagnosis and treatment; health care services, namely, leveraging health monitoring and data science to provide cancer diagnosis and treatment to patients | 01/18/2020 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| SEMA4 OPCO | Stamford, CT | 100 |
| TREELINE BIOSCIENCES | Stamford, CT | 20 |
| CARA THERAPEUTICS | Stamford, CT | 16 |
| VECTURA | Stamford, CT | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |